Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mangoceuticals, Inc. (MGRX)
NASDAQ:MGRX
Holding MGRX?
Track your performance easily
MGRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.10 - $16.81
Previous Close$2.48
Volume215.66K
Average Volume (3M)389.15K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$73.91K
Total Debt (Recent Filing)$81.51K
Price to Earnings (P/E)―
Beta-2.11
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.72
Shares Outstanding2,486,512
10 Day Avg. Volume245,072
30 Day Avg. Volume389,150
Standard Deviation0.34
R-Squared0.05
Alpha-0.08
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.46
Price to Sales (P/S)8.17
Price to Cash Flow (P/CF)-1.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Mangoceuticals, Inc. News
PremiumCompany Announcements
Mangoceuticals Expands with Patent Acquisition in Nutraceuticals
PremiumCompany Announcements
Mangoceuticals Signs Consulting Deal with CFO Johnston
PremiumCompany Announcements
Mangoceuticals Defends Against Eli Lilly Allegations
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MGRX FAQ
What was Mangoceuticals, Inc.’s price range in the past 12 months?
Mangoceuticals, Inc. lowest stock price was $2.10 and its highest was $16.81 in the past 12 months.
What is Mangoceuticals, Inc.’s market cap?
Currently, no data Available
When is Mangoceuticals, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Mangoceuticals, Inc.’s earnings last quarter?
Currently, no data Available
Is Mangoceuticals, Inc. overvalued?
According to Wall Street analysts Mangoceuticals, Inc.’s price is currently Overvalued.
Does Mangoceuticals, Inc. pay dividends?
Mangoceuticals, Inc. does not currently pay dividends.
What is Mangoceuticals, Inc.’s EPS estimate?
Mangoceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mangoceuticals, Inc. have?
Mangoceuticals, Inc. has 2,486,512 shares outstanding.
What happened to Mangoceuticals, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Mangoceuticals, Inc.?
Currently, no hedge funds are holding shares in MGRX
---
Company Description
Mangoceuticals, Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provide access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED product.
---
Technical Analysis
Relmada Therapeutics
―
Bioxcel Therapeutics
―
Evofem Biosciences
―
SELLAS Life Sciences Group
―
---